Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.

Sirtuin 2 (SIRT2) is a protein lysine deacylase that has been indicated as a therapeutic target for cancer. To further establish the role of SIRT2 in cancers, it is necessary to develop selective and potent inhibitors. Here, we report the facile synthesis of novel lysine-derived thioureas as mechanism-based SIRT2 inhibitors with anticancer activity. Compounds AF8, AF10, and AF12 selectively inhibited SIRT2 with IC50 values of 0.06, 0.15, and 0.08 μM, respectively. Compounds AF8 and AF10 demonstrated broad cytotoxicity amongst cancer cell lines, but minimal toxicity in noncancerous cells. AF8 and AF10 inhibited the anchorage-independent growth of human colorectal cancer cell line HCT116 with GI50 values of ∼7 μM. Furthermore, AF8 potently inhibited tumor growth in a HCT116 xenograft murine model, supporting that SIRT2 is a viable therapeutic target for colorectal cancer.

[1]  J. Denu,et al.  The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. , 2003, Molecular cell.

[2]  Johan Auwerx,et al.  Sirtuins as regulators of metabolism and healthspan , 2012, Nature Reviews Molecular Cell Biology.

[3]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[4]  R. Weinberg,et al.  hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase , 2001, Cell.

[5]  P. Giannakakou,et al.  A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity. , 2016, Cancer cell.

[6]  X. Wang,et al.  SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. , 2011, Cancer cell.

[7]  Wolfgang Sippl,et al.  Selective Sirt2 inhibition by ligand-induced rearrangement of the active site , 2015, Nature Communications.

[8]  Andrew H. Beck,et al.  The SIRT2 Deacetylase Stabilizes Slug to Control Malignancy of Basal-like Breast Cancer. , 2016, Cell reports.

[9]  Lee Baker,et al.  Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator , 2007, Cancer cell.

[10]  A. Sauve,et al.  Transition state of ADP-ribosylation of acetyllysine catalyzed by Archaeoglobus fulgidus Sir2 determined by kinetic isotope effects and computational approaches. , 2010, Journal of the American Chemical Society.

[11]  L. Guarente,et al.  SIRT1 and other sirtuins in metabolism , 2014, Trends in Endocrinology & Metabolism.

[12]  David Sinclair,et al.  Sirtuins in mammals: insights into their biological function. , 2007, The Biochemical journal.

[13]  L. Guarente,et al.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase , 2000, Nature.

[14]  Xiaopeng Li,et al.  A mechanism-based potent sirtuin inhibitor containing Nε-thiocarbamoyl-lysine (TuAcK). , 2011, Bioorganic & medicinal chemistry letters.

[15]  J. Marshall,et al.  Molecularly Targeted Therapy for Metastatic Colon Cancer: Proven Treatments and Promising New Agents , 2010, Gastrointestinal cancer research : GCR.

[16]  M. Raponi,et al.  KRAS mutations predict response to EGFR inhibitors. , 2008, Current opinion in pharmacology.

[17]  Hening Lin,et al.  The Substrate Specificity of Sirtuins. , 2016, Annual review of biochemistry.

[18]  Q. Hao,et al.  Efficient Demyristoylase Activity of SIRT2 Revealed by Kinetic and Structural Studies , 2015, Scientific Reports.

[19]  C. Wolberger,et al.  Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. , 2005, Molecular cell.

[20]  K. Haigis,et al.  HDAC6 and SIRT2 Regulate the Acetylation State and Oncogenic Activity of Mutant K-RAS , 2013, Molecular Cancer Research.

[21]  J. O’Sullivan,et al.  Current targeted therapies in the treatment of advanced colorectal cancer: a review , 2016, Therapeutic advances in medical oncology.

[22]  Y. Surh,et al.  Janus-faced role of SIRT1 in tumorigenesis , 2012, Annals of the New York Academy of Sciences.

[23]  E. Knoll,et al.  Mechanism of Inhibition of the Human Sirtuin Enzyme SIRT3 by Nicotinamide: Computational and Experimental Studies , 2014, PloS one.

[24]  A. Biankin,et al.  The histone deacetylase SIRT2 stabilizes Myc oncoproteins , 2012, Cell Death and Differentiation.

[25]  P. Distefano,et al.  Inhibition of SIRT1 Catalytic Activity Increases p53 Acetylation but Does Not Alter Cell Survival following DNA Damage , 2006, Molecular and Cellular Biology.

[26]  Paola Chiarugi,et al.  Anoikis molecular pathways and its role in cancer progression. , 2013, Biochimica et biophysica acta.

[27]  M. Fraga,et al.  Role of sirtuins in stem cell differentiation. , 2013, Genes & cancer.

[28]  Ruben Abagyan,et al.  Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease , 2007, Science.

[29]  Ji Cao,et al.  Direct Comparison of SIRT2 Inhibitors: Potency, Specificity, Activity‐Dependent Inhibition, and On‐Target Anticancer Activities , 2018, ChemMedChem.

[30]  Peter Fristrup,et al.  Investigating the Sensitivity of NAD+-dependent Sirtuin Deacylation Activities to NADH* , 2016, The Journal of Biological Chemistry.

[31]  A. Lièvre,et al.  KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  C. Yeh,et al.  Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients , 2016, Oncotarget.

[33]  X. Niu,et al.  Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth , 2016, Oncotarget.

[34]  Q. Hao,et al.  Deacylation Mechanism by SIRT2 Revealed in the 1'-SH-2'-O-Myristoyl Intermediate Structure. , 2017, Cell chemical biology.

[35]  M. Weyand,et al.  Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism , 2013, Proceedings of the National Academy of Sciences.

[36]  I. Shin,et al.  A potent and selective small molecule inhibitor of sirtuin 1 promotes differentiation of pluripotent P19 cells into functional neurons , 2016, Scientific Reports.